drugset / Trial / NCT00406783

Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

NCT00406783

Phase 3 Completed 547 enrolled Organon and Co
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will investigate the effectiveness of desloratadine in treating subjects with allergic rhinitis (AR) who meet the criteria for intermittent allergic rhinitis.

Timeline

Start
2006-08
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Desloratadine Small molecule 5 mg